Abstract
Objectives
Lung cancer is the most common form of cancer and the leading cause of cancer death. For familial lung cancer, identification of causing genetic factors is essential for prevention and control of non-lung cancer in carriers.
Materials and methods
We studied two generations of a family with suspected inherited lung cancer susceptibility. Four individuals in this family had lung adenocarcinoma. To identify the gene(s) that cause the lung cancer in this pedigree, we extracted DNA from the peripheral blood of four cancer individuals and blood from three cancer-free family members as the control and performed whole-genome sequencing. Our filtering strategy includes, assessment of allele frequency, functional affection on amino acids, mutation accumulation, phased blocks and evolution analysis towards the alterations.
Results
We identified two possible mutations, including PLEKHM2 (D134N) and MCC (R448Q) in all affected family members but did not found in the control group. Then, we performed a genetic susceptibility screening for 10 non-lung cancer relatives and found two individuals with PLEKHM2 (D134N) mutation, two with MCC (R448Q) mutation and one carrying both mutations. 3 carriers performed LDCT scan and 2 of them carried MCC (R448Q) also had ground-glass opacity (GGO) lesion in their lung.
Conclusion
Our data suggested that WGS together with our filtering strategy was successful in identifying PLEKHM2 (D134N) and MCC (R448Q) as the possible driver mutations in this family. Genetic susceptibility screening of non-lung cancer carriers will be a useful approach to prevent and control lung cancer in families with high-risk for the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed dur-ing the current study are available from the corresponding author on reasonable request.
References
Abyzov A, Urban AE, Snyder M et al (2011) CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res 21:974–984
Al Bkhetan Z, Zobel J, Kowalczyk A, , et al., (2019) Exploring effective approaches for haplotype block phasing.BMC Bioinformatics,. 30:540
Arbour KC, Riely GJ.(2019)Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.JAMA. 322:764–774.
Barta JA, Powell CA, Wisnivesky JP (2019) Global epidemiology of lung cancer. Ann Glob Health 85:8
Bell DW, Gore I, Okimoto RA et al (2005) Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet 37:1315–1316
Chen K, Wallis JW, McLellan MD et al (2009) Breakdancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 6:677–681
Chen HY, Yu SL, Ho BC et al (2015) R331W missense mutation of oncogene YAP1 Is a germline risk allele for lung adenocarcinoma with medical actionability. J Clin Oncol : off J Am Soc Clin Oncol 33:2303–2310
Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132
Cheng YI, Gan YC, Liu D, et al.,(2019)Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.BMC Cancer. 19: 1068.
DePristo MA, Banks E, Poplin R et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43:491–498
Fagerberg L, Hallstrom BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular Cellular Proteomics : MCP 13:397–406
Fan, X., T.E. Abbott, D. Larson, et al., (2014) Break dancer: identification of genomic structural variation from paired-end read mapping, current protocols in bioinformatics. 45 15 (6) 1–11
Khurana E, Fu Y, Colonna V et al (2013) Integrative annotation of variants from 1092 humans: application to cancer genomics. Science 342:1235587
Li H, Durbin R (2009) Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 25:1754–1760
Li H, Durbin R (2010) Fast and accurate long-read alignment with burrows-wheeler transform. Bioinformatics 26:589–595
McKenna A, Hanna M, Banks E et al (2010) The genome analysis toolkit: a map reduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297–1303
Nishisho I, Nakamura Y, Miyoshi Y et al (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665–669
Ohtsuka K, Ohnishi H, Kurai D et al (2011) Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation. J Clin Oncol : off J Am Society Clin Oncol 29:e191–e192
Oxnard GR, Binder A, Janne PA (2013) New targetable oncogenes in non-small-cell lung cancer, Journal of clinical oncology : Off J Am Soc Clin Oncol 31:1097–1104
Palmer JD, Zaorsky NG, Witek M et al (2014) Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer. J Thorac Dis 6:387–398
Roach JC, Glusman G, Smit AF et al (2010) Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328:636–639
Roach JC, Glusman G, Hubley R et al (2011) Chromosomal haplotypes by genetic phasing of human families. Am J Hum Genet 89:382–397
Robichaux JP, Le X, Vijayan RSK et al (2021) Structure-based classification predicts drug response in EGFR-mutant NSCLC. Nature 597:732–737
Samarelli AV, Masciale V, Aramini B et al (2021) Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. Int J Mol Sci 22:12179
Sholl LM, Aisner DL, Varella-Garcia M et al (2015) Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: the lung cancer mutation consortium experience. J Thorac Oncol 10:768–777
Ulivi P, Zoli W, Capelli L et al (2013) Target therapy in NSCLC patients: relevant clinical agents and tumour molecular characterisation. Mol Clin Oncol 1:575–581
van Noesel J, van der Ven WH, van Os TA et al (2013) Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation. J Clin Oncol : off J Am Soc Clin Oncolo 31:e161–e164
Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38:e164
Wang S, Lou N, Luo R, et al.,(2022)Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC.J Transl Med. 31:248.
Yamamoto, H., K. Higasa, M. Sakaguchi, et al., (2014)Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas, Journal of the National Cancer Institute. 106 : djt338
Funding
This work was supported by Tongzhou District Science and Technology Committee [Grant number KJ2017CX049]; and Beijing Municipal Administration of Hospitals’ Ascent Plan [Grant number DFL20151501].
Author information
Authors and Affiliations
Contributions
Ning Xiao wrote the main manuscript text. Zhidong Liu and Yi Han Guided the design and conduct of research. Xiaoqing Cao Participated in the design, data collection and writing of the experiment.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
All authors of this manuscript have directly participated in its planning and execution, and declare no potential conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
432_2023_4616_MOESM1_ESM.tif
Supplementary file1 Process of SNPs and INDELs filtering from raw variants.GATK, Genome Analysis Toolkit; AD, autosomal dominant; AR, autosomal recessive (TIF 55 KB)
432_2023_4616_MOESM2_ESM.pdf
Supplementary file2 Identification of C1orf195, PLEKHM2 and MCC mutation: c.349C>N(P117T), c.400G>A (D134N) and c.1343G>N (R448Q) in the relatives of the affected and unaffected individuals of the original family covering four generations (PDF 1617 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xiao, N., Cao, X., Liu, Z. et al. Two germline mutations can serve as genetic susceptibility screening makers for a lung adenocarcinoma family. J Cancer Res Clin Oncol 149, 6541–6548 (2023). https://doi.org/10.1007/s00432-023-04616-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-04616-2